McKesson Corporation logo

McKesson Corporation (MCK)

Market Closed
11 Jul, 20:00
NYSE NYSE
$
709. 59
-4.95
-0.69%
$
89.99B Market Cap
17.39 P/E Ratio
2.84% Div Yield
364,140 Volume
25.95 Eps
$ 714.54
Previous Close
Day Range
706.1 710.79
Year Range
464.42 737.89
Want to track MCK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 25 days
McKesson (MCK) Rises Higher Than Market: Key Facts

McKesson (MCK) Rises Higher Than Market: Key Facts

McKesson (MCK) concluded the recent trading session at $730.80, signifying a +1.82% move from its prior day's close.

Zacks | 4 weeks ago
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 month ago
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Here is how McKesson (MCK) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.

Zacks | 1 month ago
Why McKesson (MCK) is a Top Value Stock for the Long-Term

Why McKesson (MCK) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
Here's Why McKesson (MCK) is a Strong Momentum Stock

Here's Why McKesson (MCK) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 month ago
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock

Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 month ago
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?

MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?

Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.

Zacks | 1 month ago
MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?

MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?

McKesson's MCK shares have gained 4.4% following its fourth-quarter fiscal 2025 earnings release on May 9. The post-earnings upside reflects growing investor confidence in McKesson's strategic execution and long-term positioning, underpinned by record full-year revenues of $359 billion and a 20% year-over-year increase in adjusted earnings per share (to $33.05).

Zacks | 1 month ago
McKesson: Sustained Rally Backed By Strong Financials

McKesson: Sustained Rally Backed By Strong Financials

The stock price of McKesson has maintained a strong upward trend throughout multiple years because of its solid financial performance and dedicated investor support which creates a defensive investment opportunity. The company achieves strong revenue and EPS growth through its expanding oncology, biopharmaceutical and GLP-1 therapy sales, which counterbalance the typical thin margins of the sector. The company's strategic focus on high-growth segments together with its divestment of slow-growth units makes McKesson an attractive long-term investment despite its high valuation and low yield.

Seekingalpha | 1 month ago
McKesson To Spin-Off Its Medical-Surgical Solutions Business

McKesson To Spin-Off Its Medical-Surgical Solutions Business

Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical-Surgical Solutions segment into an independent company (NewCo) (for more information, visit spinoffresearch.com). McKesson is committed to exploring all opportunities to execute a separation in a manner that maximizes shareholder value and anticipates providing more information as appropriate on the form and timing as the process progresses.

Forbes | 1 month ago
3 Reasons Growth Investors Will Love McKesson (MCK)

3 Reasons Growth Investors Will Love McKesson (MCK)

McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 month ago
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 month ago
Loading...
Load More